India drugmaker stocks exception in Asian rout

Last Updated: Thursday, September 3, 2015, 19:37

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.

Sun Pharma may file new drug application with USFDA: Shanghvi

Last Updated: Thursday, July 30, 2015, 20:47

India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.

Sun Pharma slumps, heads towards biggest fall ever

Last Updated: Tuesday, July 21, 2015, 09:42

Shares in Sun Pharmaceutical Industries slumped 16 percent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.

Lupin shares gain on inclusion in Sensex

Last Updated: Monday, June 22, 2015, 13:16

Shares of drugmaker Lupin rose by almost 2 percent after the stock became part of the BSE benchmark Sensex from on Monday.

Sun Pharma Q3 net profit declines 7% to Rs 1,425 crore

Last Updated: Saturday, February 14, 2015, 16:14

Drug major Sun Pharma on Saturday reported 6.92 percent decline in consolidated net profit at Rs 1,425.07 crore for the third quarter ended December 31, 2014-15, saying it was hit by supply constraints.

HC stays suspension order of Maha FDA on Dr Reddy's C&F agent

Last Updated: Friday, January 9, 2015, 14:18

Dr Reddy's Laboratories on Friday said the Bombay High Court has granted an interim stay on an order issued by the Maharashtra drug controller (FDA) for a one-month suspension of wholesale licence of the company's clearing and forwarding agent in Bhiwandi near Thane.